318 related articles for article (PubMed ID: 33015791)
1. Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance.
Wang SQ; Shuai ZF; Zhang XJ; Wu T; Dong HY; Liu T; Wen QT; Yu XW
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9487-9496. PubMed ID: 33015791
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of circulating tumor cells from lung cancer patients using microfluidic chip.
Qian C; Wu S; Chen H; Zhang X; Jing R; Shen L; Wang X; Ju S; Jia C; Cong H
Clin Exp Med; 2018 May; 18(2):191-202. PubMed ID: 29445889
[TBL] [Abstract][Full Text] [Related]
3. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
Chen X; Wang X; He H; Liu Z; Hu JF; Li W
PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer.
Li J; Liao Y; Ran Y; Wang G; Wu W; Qiu Y; Liu J; Wen N; Jing T; Wang H; Zhang S
BMC Pulm Med; 2020 Oct; 20(1):274. PubMed ID: 33081780
[TBL] [Abstract][Full Text] [Related]
5. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
[TBL] [Abstract][Full Text] [Related]
6. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer.
Dong J; Zhu D; Tang X; Lu D; Qiu X; Li B; Lin D; Li L; Liu J; Zhou Q
PLoS One; 2019; 14(7):e0220306. PubMed ID: 31348821
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.
Shishido SN; Carlsson A; Nieva J; Bethel K; Hicks JB; Bazhenova L; Kuhn P
J Transl Med; 2019 Aug; 17(1):294. PubMed ID: 31462312
[TBL] [Abstract][Full Text] [Related]
10. Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.
Lou J; Ben S; Yang G; Liang X; Wang X; Ni S; Han B
PLoS One; 2013; 8(12):e80458. PubMed ID: 24324600
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
[TBL] [Abstract][Full Text] [Related]
13. Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.
Murlidhar V; Reddy RM; Fouladdel S; Zhao L; Ishikawa MK; Grabauskiene S; Zhang Z; Lin J; Chang AC; Carrott P; Lynch WR; Orringer MB; Kumar-Sinha C; Palanisamy N; Beer DG; Wicha MS; Ramnath N; Azizi E; Nagrath S
Cancer Res; 2017 Sep; 77(18):5194-5206. PubMed ID: 28716896
[TBL] [Abstract][Full Text] [Related]
14. Detecting circulating tumor cells in patients with advanced non-small cell lung cancer.
Xu YH; Zhou J; Pan XF
Genet Mol Res; 2015 Sep; 14(3):10352-8. PubMed ID: 26345975
[TBL] [Abstract][Full Text] [Related]
15. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.
Liu DG; Xue L; Li J; Yang Q; Peng JZ
Cancer Biomark; 2018; 22(3):417-426. PubMed ID: 29758927
[TBL] [Abstract][Full Text] [Related]
17. Analysis of circulating tumor cells from lung cancer patients with multiple biomarkers using high-performance size-based microfluidic chip.
Gao W; Yuan H; Jing F; Wu S; Zhou H; Mao H; Jin Q; Zhao J; Cong H; Jia C
Oncotarget; 2017 Feb; 8(8):12917-12928. PubMed ID: 28039472
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of recombinant virus-specific detection for viable circulating tumor cells in lung cancer patients].
Xiao Y; Liu S; Wang ZZ; Chen Y; Li J; Li F
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Feb; 42(2):101-105. PubMed ID: 30704181
[No Abstract] [Full Text] [Related]
19. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
Zhou J; Dong F; Cui F; Xu R; Tang X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.
Kanayama M; Kuwata T; Mori M; Nemoto Y; Nishizawa N; Oyama R; Matsumiya H; Taira A; Shinohara S; Takenaka M; Yoneda K; Kuroda K; Ohnaga T; Tanaka F
Cancer Sci; 2022 Mar; 113(3):1028-1037. PubMed ID: 34964211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
